C12N 2795/10223
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2795/10223 (Virus like particles [vlp]) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 4
- Inventors
- 11
- Latest grant
- 23 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
- Bacteriophage variants having extended host-range, methods for preparation and uses thereof in transducing nucleic acids into hosts of interest23 Aug 2022US 11,419,908 B2Technology Innovation Momentum Fund (Israel) Limited Partnership
- Presentation of bioactive proteins10 Dec 2019US 10,501,744 B2Indiana University Research and Technology Corporation
- CYP-P22 biocatalytic nanoparticles with cytochrome P450 activity for prodrug activation19 Nov 2019US 10,480,012 B2Universidad Nacional Autonoma De Mexico
- Bacteriophage variants having extended host-range, methods for preparation and uses thereof in transducing nucleic acids into hosts of interest5 Oct 2023US 2023/0310525 A1Technology Innovation Momentum Fund (Israel) Limited Partnership
- Bacteriophage variants having extended host-range, methods for preparation and uses thereof in transducing nucleic acids into hosts of interest24 Oct 2019US 2019/0321422 A1Technology Innovation Momentum Fund (Israel) Limited Partnership
- Cyp-p22 biocatalytic nanoparticles with cytochrome p450 activity for prodrug activation15 Nov 2018US 2018/0327780 A1Universidad Nacional Autonoma De Mexico
- Presentation of bioactive proteins9 Nov 2017US 2017/0321220 A1Indiana University Research and Technology Corporation
- Drug delivery vehicles19 Nov 2015US 2015/0328322 A1Board of Regents, The University of Texas System
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.